Placebo matching BI 765845, BI 765845, Gadovist 1.0 mmol/ml solution for injection clinical trials

Randomised study for double-blind, placebo-controlled evaluation of BI 765845 on top of standard of care in patients with myocardial infarction

This study is testing a new medicine, BI 765845, for people who have recently had a heart attack. Researchers want to see if adding this medicine to usual care can help reduce the damage to the heart muscle. It's a key step in understanding if this new treatment could be helpful.